Eric Rambeaux, CEO of IOME Bio
DiogenX
Visibility and market recognition for biotech startup
Robocath launches new robotic platform R-One+
© Robocath
Yposkesi welcomes French ministers to newly constructed 5,000m2 industrial site – under ‘Choose France’ government scheme
© Courtesy of Yposkesi
DiogenX raises €27.5M Series A financing to advance its first-in-class regenerative treatment for type 1 diabetes towards clinical development
Benjamin Charles, CEO at DiogenX – © DiogenX
Ribonexus appoints Dr. David Howat as Chief Development Officer
David Howat, Chief Development Officer at Ribonexus
Bioxodes presents latest developments at key international conferences – on first-in-class drug candidate for patients with intracerebral hemorrhage
BiPER Therapeutics
Visibility and market recognition for biotech startup
Enalees investit dans un nouveau laboratoire de développement et de production protéomique pour le marché vétérinaire
